ATRA logo

Atara Biotherapeutics, Inc


ATRA: Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).


Show ATRA Financials

Consumer Interest
SEC Filings

Recent trades of ATRA by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by ATRA's directors and management

Government lobbying spending instances

  • $60,000 Jul 13, 2023 Issue: Health Issues
  • $60,000 Apr 07, 2023 Issue: Health Issues
  • $60,000 Jan 18, 2023 Issue: Health Issues
  • $60,000 Oct 11, 2022 Issue: Health Issues
  • $60,000 Jul 20, 2022 Issue: Health Issues
  • $60,000 Apr 20, 2022 Issue: Health Issues
  • $60,000 Jan 09, 2022 Issue: Health Issues
  • $60,000 Oct 14, 2021 Issue: Health Issues
  • $60,000 Jul 19, 2021 Issue: Health Issues
  • $40,000 Apr 19, 2021 Issue: Health Issues
U.S. Patents

New patents grants

  • Patent Title: Administration of an anti-activin-a compound to a subject Jan. 03, 2023
  • Patent Title: Variant activin receptor polypeptides and uses thereof Aug. 06, 2013
  • Patent Title: Stabilized activin iib receptor polypeptides and uses thereof Apr. 02, 2013
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of ATRA in WallStreetBets Daily Discussion


Recent insights relating to ATRA

CNBC Recommendations

Recent picks made for ATRA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ATRA

Corporate Flights

Flights by private jets registered to ATRA